CGX-195

Asset

Stabilizes mutant AAT, reduces polymerization, and increases secretion of functional AAT.

Stage
Preclinical
Modality
Small molecule
Target
SERPINA1
1
Indication
0
Trials
1
Developer

Indications

1

In the full profile

  • Targets and what it contains1
  • Owner and partners1
  • Evidence for its targets1
  • Competitors1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets